Telitacicept found to reduce gMG severity in Phase 3 trial in China
Treatment with Remegen’s telitacicept over nearly six months safely reduced disease severity in adults with generalized myasthenia gravis…
Andrea Lobo is a Science writer at Bionews since 2022. She holds a PhD in Cell Biology/Neurosciences, where she studied the molecular pathways that contribute to neurodegeneration/neuroprotection in stroke biology. Between 2011 and 2021, she worked as a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, focused on the molecular mechanisms involved in drug addiction, particularly neuronal plasticity and remodeling induced by amphetamines. As a research scientist for 19 years, Andrea also participated in academic projects in other research fields, including gene regulation, cancer, and rare diseases. During her professional journey, Andrea also developed her science writing skills by writing/editing scientific papers and grant proposals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Treatment with Remegen’s telitacicept over nearly six months safely reduced disease severity in adults with generalized myasthenia gravis…
Myasthenia gravis (MG) is associated with a high personal and societal economic burden, due to work engagement and income…
People with myasthenia gravis (MG) who have more severe disease when they are diagnosed, are older at its onset,…
A 39-year-old woman with severe myasthenia gravis (MG) associated with a thymoma, a thymus tumor, responded favorably to treatment…
People newly diagnosed with myasthenia gravis (MG) in England experience a high disease burden, with about two-thirds having at…
People with myasthenia gravis (MG) have a higher risk of developing cancer in organs other than the thymus, particularly…
The incidence of myasthenia gravis (MG) is increasing in the Czech Republic, with about 40% of the patients being…
Soleo Health, a pharmacy services company specializing in infusion treatments, has opened a new ambulatory center in the Knoxville,…
An investigator-initiated clinical trial will assess the safety and efficacy of NKX019, Nkarta’s investigational natural killer (NK) cell…
The presence of antibodies targeting titin, a type of muscle protein, in patients with myasthenia gravis (MG) not associated…
Get regular updates to your inbox.